Sino Biopharmaceutical Ltd (SBMFF)
0.43
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Sino Biopharmaceutical Enterprise Value: 8.600B for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 8.600B |
| November 13, 2024 | 8.600B |
| November 12, 2024 | 8.600B |
| November 11, 2024 | 8.600B |
| November 08, 2024 | 8.600B |
| November 07, 2024 | 8.476B |
| November 06, 2024 | 8.476B |
| November 05, 2024 | 9.383B |
| November 04, 2024 | 9.383B |
| November 01, 2024 | 9.383B |
| October 31, 2024 | 9.383B |
| October 30, 2024 | 9.383B |
| October 29, 2024 | 9.383B |
| October 28, 2024 | 9.383B |
| October 25, 2024 | 9.383B |
| October 24, 2024 | 9.383B |
| October 23, 2024 | 9.383B |
| October 22, 2024 | 9.383B |
| October 21, 2024 | 9.383B |
| October 18, 2024 | 9.328B |
| October 17, 2024 | 9.328B |
| October 16, 2024 | 9.328B |
| October 15, 2024 | 9.328B |
| October 14, 2024 | 9.328B |
| October 11, 2024 | 9.328B |
| Date | Value |
|---|---|
| October 10, 2024 | 9.328B |
| October 09, 2024 | 9.328B |
| October 08, 2024 | 9.328B |
| October 07, 2024 | 9.328B |
| October 04, 2024 | 9.328B |
| October 03, 2024 | 9.328B |
| October 02, 2024 | 9.328B |
| October 01, 2024 | 9.328B |
| September 30, 2024 | 9.328B |
| September 27, 2024 | 9.328B |
| September 26, 2024 | 9.328B |
| September 25, 2024 | 8.556B |
| September 24, 2024 | 8.556B |
| September 23, 2024 | 8.556B |
| September 20, 2024 | 8.556B |
| September 19, 2024 | 7.717B |
| September 18, 2024 | 7.717B |
| September 17, 2024 | 7.717B |
| September 16, 2024 | 7.717B |
| September 13, 2024 | 7.717B |
| September 12, 2024 | 7.717B |
| September 11, 2024 | 7.717B |
| September 10, 2024 | 7.717B |
| September 09, 2024 | 7.717B |
| September 06, 2024 | 7.717B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.289B
Minimum
Oct 02 2023
29.10B
Maximum
Jul 20 2020
13.72B
Average
11.72B
Median
Enterprise Value Benchmarks
| HUTCHMED (China) Ltd | 2.171B |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 71.42M |
| Prenetics Global Ltd | 9.425M |
| Uni-Bio Science Group Ltd | 13.51M |
Enterprise Value Related Metrics
| Earnings Yield | 3.94% |
| Operating Earnings Yield | 10.54% |
| Normalized Earnings Yield | 3.884 |